Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q2 2024 (June 30)4holders
0new positions
0sold out
1famous investor
$0.33avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($61K), Clear Street LLC ($20K) and Citadel Advisors ($14K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 15,504 shares bought and 3,162 shares sold, net +12,342 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Armistice Capital, LLC | — | No change | 204,082 | $61K |
| Clear Street LLC | — | Add +30.7% | 66,016 | $20K |
| Citadel Advisors | — | Reduce -8.1% | 22,221 | $14K |
| Warberg Asset Management LLC | — | Reduce -7.7% | 14,476 | $6K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.